Physician profile
Eric W Bantz
NPI 1124172598
$8,211.37
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,269 · 2020: $1,907 · 2021: $1,958 · 2022: $2,077.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,648.90 | 2019-2022 | |
| Glaxosmithkline, LLC. | $843.82 | 2019-2022 | |
| Genzyme Corporation | $608.96 | 2019-2022 | |
| Csl Behring | $473.83 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $467.20 | 2019-2022 | |
| Kaleo, INC. | $412.14 | 2019-2022 | |
| Pfizer INC. | $364.19 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $340.56 | 2019-2022 | |
| Grifols USA, LLC | $334.76 | 2019-2022 | |
| Abbvie INC. | $316.28 | 2022 | |
| Optinose US, INC. | $294.10 | 2019-2021 | |
| Covis Pharma Gmbh | $267.06 | 2019-2022 | |
| Alk-Abello, INC | $229.96 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $214.70 | 2020-2022 | |
| Bio Products Laboratory USA, INC. | $196.82 | 2019-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $195.05 | 2019-2021 | |
| Pharming Healthcare, INC. | $160.46 | 2019-2022 | |
| Genentech USA, INC. | $145.75 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $126.72 | 2019-2022 | |
| Octapharma USA, INC. | $118.35 | 2019-2022 | |
| Eyevance Pharmaceuticals LLC | $75.85 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.30 | 2020-2022 | |
| Amgen INC. | $55.05 | 2022 | |
| Uswm, LLC | $52.04 | 2021 | |
| Aimmune Therapeutics, INC. | $50.19 | 2020-2022 | |
| Biocryst US Sales Co., LLC | $41.02 | 2021-2022 | |
| Shire North American Group INC | $28.26 | 2019 | |
| Incyte Corporation | $19.25 | 2022 | |
| Horizon Therapeutics Plc | $14.79 | 2020 | |
| Merck Sharp & Dohme LLC | $14.51 | 2021 | |
| Leo Pharma INC. | $14.24 | 2022 | |
| Phadia US INC. | $13.26 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Bantz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.